Prostate Cancer and Prostatic Diseases, 1476-5608

Tidskrift

Fler filtreringsmöjligheter
  1. 2019
  2. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer

    Subhayan Chattopadhyay, Otto Hemminki, Asta Försti, Kristina Sundquist, Jan Sundquist & Kari Hemminki, 2019, I : Prostate Cancer and Prostatic Diseases. 22, 1, s. 143-149

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2013
  4. A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells.

    Giuseppe Lippolis, Anders Edsjö, U-H Stenman & Anders Bjartell, 2013, I : Prostate Cancer and Prostatic Diseases. 16, 2, s. 145-150 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists

    N. D. Shore, Per-Anders Abrahamsson, J. Anderson, E. D. Crawford & P. Lange, 2013, I : Prostate Cancer and Prostatic Diseases. 16, 1, s. 7-15

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  6. 2012
  7. 2010
  8. Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.

    Anna K Dahlman, Anders Edsjö, Christer Halldén, J L Persson, S W Fine, Hans Lilja, W Gerald & Anders Bjartell, 2010, I : Prostate Cancer and Prostatic Diseases. 13, s. 369-375

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2009
  10. Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia

    J. Hammarsten, J-E Damber, Magnus Karlsson, T. Knutson, O. Ljunggren, C. Ohlsson, R. Peeker, U. Smith & D. Mellstrom, 2009, I : Prostate Cancer and Prostatic Diseases. 12, 2, s. 160-165

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2006
  12. Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer

    Karl Mikael Kalkner, Stefan Acosta, Ola Thorsson, Hans Frederiksen, A Nilsson, Bengt Gustavsson, Marie Elingsbo, M Stridsberg & Per-Anders Abrahamsson, 2006, I : Prostate Cancer and Prostatic Diseases. 9, 1, s. 92-98

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2004
  14. Long-term testosterone stimulation induces hyperplasia in the guinea-pig prostate.

    Stefan Acosta, Nishtman Dizeyi, R Feinstein, Stefan Pierzynowski & Per-Anders Abrahamsson, 2004, I : Prostate Cancer and Prostatic Diseases. 7, 3, s. 227-231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2000
  16. Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues

    Anders Bjartell, A Paju, U H Stenman, V Vaisanen, G Aumuller, E Diamandis, Charlotte Becker & Hans Lilja, 2000, I : Prostate Cancer and Prostatic Diseases. 3, Suppl 1, s. S7-S7

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. 1999
  18. Early Diagnosis and Staging.

    Hans Lilja, 1999, I : Prostate Cancer and Prostatic Diseases. 2, S1, s. 15-18

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift